News & Events
Biomarkers of inflammation in progressive MS
There is a need to identify direct biomarkers of inflammation within the central nervous system
A non-invasive method to identify MS progression
Researchers are looking for new biomarkers of disease, which could also recognise progression of MS in a…
Early identification of progressive multifocal leukoencephalopathy in patients on natalizumab
A method for early detection of Natalizumab-associated progressive multifocal leukoencephalopathy in the absence of clinical symptoms
Predictive factors for developing MS
Identifying risk factors for developing further attacks and disability accumulation in patients with “clinically isolated syndrome"
Breaking down the barriers
One girl’s story of fighting for success in Mumbai, India
Take the Pledge
The MS Society of Canada asks Canadians to pledge, donate and share
$28 million USD investment for new research
The National MS Society invests $28 million USD in new MS research projects
New educational comic for children
MS Australia has endorsed an educational comic to make MS information more accessible for children
Characteristics of primary progressive MS
Researchers in Canada have investigated the natural history of 500 people with primary progressive MS
Hematopoietic stem cells and MS
The results of a multi-centre, phase II, randomized trial
MSIF staff celebrate World MS Day
Find out how staff from the MSIF office in London celebrated World MS Day
New treatment for spasticity and pain
Radial shock wave therapy has been used to treat spasticity and pain in Italy